GlassScriptPhysician profile
Ronald H Mc Lean
NPI 1861549388
$419.26
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.42 · 2021: $296 · 2022: $105.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $205.40 | 2021-2022 | |
| Smith+Nephew, INC. | $114.77 | 2021-2022 | |
| Imbed Biosciences INC. | $39.67 | 2022 | |
| Abbvie INC. | $25.68 | 2021 | |
| Misonix INC | $18.42 | 2020 | |
| Tactile Systems Technology INC | $15.32 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Mc Lean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.